FDA’s CVM is evaluating the design of studies intended to support the standard of effectiveness for new animal drugs to prevent heartworm disease in dogs. The FDA is requesting public input on evaluating these products to assist in the potential development of alternative study designs.
via What's New: Animal & Veterinary https://ift.tt/2LpzEVe
No comments:
Post a Comment